Top 10 companies by global revenue from orphan drugs 2028

Published by
Matej Mikulic,
May 22, 2024
This statistic shows a projection of the top 10 global pharmaceutical companies based on revenue generated by orphan drugs in 2028. For that year, it is projected that Roche's orphan drugs revenue will total 16.8 billion U.S. dollars. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.

Forecast of leading 10 pharmaceutical companies by global orphan drug revenue in 2028 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2024

Region

Worldwide

Survey time period

as of February 2024

Supplementary notes

Products that have orphan and non-orphan drug designations and are expected to generate less than 50% of their sales in 2024 from their orphan-designated indication/s, are excluded from this statistic. This has led to the exclusion of therapies such as Avastin, Opdivo, Enbrel, Herceptin, Humira and Remicade.

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Orphan drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu